Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
about
What happens to cardiovascular system behind the undetectable level of HIV viremia?Cardiovascular Disease, Statins, and HIVMonocyte bioenergetic function is associated with body composition in virologically suppressed HIV-infected womenInflammation, Immune Activation, and Antiretroviral Therapy in HIVTreatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity.Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy.Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group StuChanges in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV.SIV/SHIV Infection Triggers Vascular Inflammation, Diminished Expression of Krüppel-like Factor 2 and Endothelial Dysfunction.HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".Inflammation, immune activation, and cardiovascular disease in HIV.One of the immune activation profiles observed in HIV-1-infected adults with suppressed viremia is linked to metabolic syndrome: The ACTIVIH study.Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral TherapyKynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection.Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV.Altered Monocyte and Endothelial Cell Adhesion Molecule Expression Is Linked to Vascular Inflammation in Human Immunodeficiency Virus InfectionEquivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide.Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionLipid Abnormalities and Inflammation in HIV Inflection.Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.Gut-homing Δ42PD1(+)Vδ2 T cells promote innate mucosal damage via TLR4 during acute HIV type 1 infection.Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV.Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s.Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV.HIV as a Cause of Immune Activation and Immunosenescence.HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy
P2860
Q26749024-13E23A8E-532F-4207-9DC5-1A134DB73C8EQ30245373-4E624AFA-538B-48E1-AB13-85957DEEAB37Q33555718-7D2E680D-8371-406D-AECF-63B3B401E6D8Q33912595-E127A46E-F1C0-4604-8155-66B967A9E5F9Q33917580-0C6EC078-1B99-4753-A1C6-C050A2D576A5Q35994939-4135ED66-16D2-4CF5-876D-3F8046081DBBQ36063953-2127E3AD-BC88-46CD-8286-F49600A93F67Q36341298-1FB6D976-E02A-41A6-91A2-0FC0E8DE7495Q36436569-AF4D612F-7025-460C-8A09-D1BFD6250B1AQ36745235-5013DAA6-4F33-4985-846F-1E0BAA8AD2D7Q36956654-9930B5E4-BF44-46F5-BD07-90D8D2AC38C6Q36957752-A31EAD89-2953-421B-8A6D-44081650524AQ37034835-BCACE8A6-C3C1-4612-8895-3E89A803AB07Q37149855-E993E0D4-192D-4FAC-B283-1C51243C5352Q37182624-26458C50-7B27-48B8-A7DF-FC88F08693EFQ37294964-4EF31663-4E23-4FA3-83E7-4E8F0E3C9DDCQ37543675-B5E0046C-328F-4235-ACFF-67BB6A22C102Q37604553-67C43141-43FF-402C-BE38-3BF12A9D868CQ38749963-694A635D-0161-4ED2-BAA8-F3BB943D93B7Q38849283-D83D5220-A5AC-4179-8F65-99C706BC4423Q39414284-A486DF21-B583-44DD-8EE1-A755C0BB0EE4Q40083110-F7527715-F980-4552-B219-2228496BC952Q40276628-E3E44238-7B72-45C7-816F-6C6E7E496BC4Q40311279-C9603099-5087-43C6-960A-337B7E7AF07CQ40529577-B002BF58-379A-414A-BB68-9BD0D0C493A1Q44360506-1449C06A-3F72-4F34-805F-20EC0CE32351Q47151081-330A696B-B31A-45E9-A974-5FCE18AAA028Q50045865-3D825B79-2B2D-4712-8167-EBCED222875CQ58549748-9974DFA9-90E9-4B1A-B0E0-C91817B6C36C
P2860
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
@ast
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
@en
type
label
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
@ast
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
@en
prefLabel
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
@ast
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation.
@en
P2093
P2860
P1476
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation
@en
P2093
Benigno Rodriguez
Brian Clagett
Brian Ferrari
David A Zidar
Grace A McComsey
Heather A Pilch-Cooper
Michael M Lederman
Scott F Sieg
Shawn Rose
Steven Juchnowski
P2860
P304
P356
10.1097/QAI.0000000000000566
P407
P577
2015-06-01T00:00:00Z